What Is the Prognostic Value of (y)pT and (y)pN?

Chapter

Abstract

The TNM classification has been modified over the years, up to the seventh edition, attempting to follow the pace of progress and evidence-based developments in oncology. According to TNM authors, the main stage groupings have remained unchanged and are still equivalent to Dukes’ classification. However, major issues relate to subcategories which so-called should still collapse back into those of the 1987 classification and thus are still comparable to Dukes’. The prognostic values of various subcategories do not always achieve the standards of evidence-based that one would/could/should expect. The sequential changes allocate patients to different stages (stage migration) giving lead to therapeutical consequences for the individual patients and difficulties with ongoing clinical trials, databases, registries, etc. Important issues concerning (y)pT and (y)pN to clarify are the tumoural deposits and the number of positive versus the total number of lymph nodes examined and especially the ratio. TNM authors have published principles on ‘the process for continuous improvement of the TNM classification’, a process that is increasingly evidence-based. TNM classification is and should remain a worldwide benchmark for reporting the extent of malignant disease and the major prognostic factor in predicting the outcome of patients.

Keywords

Lymph Node Rectal Cancer Sentinel Lymph Node Regional Lymph Node Total Mesorectal Excision 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Bell S, Sasaki J, Sinclair G et al (2009) Understanding the anatomy of lymphatic drainage and the use of blue-dye mapping to determine the extent of lymphadenectomy in rectal cancer surgery: unresolved issues. Colorectal Dis 11:3443–3449CrossRefGoogle Scholar
  2. 2.
    Ceelen W, Van Nieuwenhove Y, Pattyn P (2010) Prognostic value of lymph node ratio in stage III colorectal cancer: a systemic review. Ann Surg Oncol 17:2847–2855PubMedCrossRefGoogle Scholar
  3. 3.
    Chin CC, Wang JY, Yeh CY,et al (2009) Metastatic lymph node ratio is a more precise predictor of prognosis than number of lymph node metastases in stage III colon cancer. Int J Colorectal Dis 24:1297-1302PubMedCrossRefGoogle Scholar
  4. 4.
    Chou JF, Row D, Gonen M et al (2010) Clinical and pathologic factors that predict lymph node yield from surgical specimens in colorectal cancer. Cancer 116:2560–2570PubMedCrossRefGoogle Scholar
  5. 5.
    Compton CC, Fielding LP, Burgart LJ et al (2000) Prognostic factors in colorectal cancer; College of American Pathologists consensus statement 1999. Arch Pathol Lab Med 124:979–994PubMedGoogle Scholar
  6. 6.
    Compton CC, Greene FL (2004) The staging of colorectal cancer: 2004 and beyond. CA Cancer J Clin 54:295–308PubMedCrossRefGoogle Scholar
  7. 7.
    Dekker JWT, Peeters KC, Putter H et al (2010) Metastatic lymph node ratio in stage III rectal cancer, prognostic significance in addition to the 7th edition of the TNM classification. Eur J Surg Oncol 36:1180–1186PubMedCrossRefGoogle Scholar
  8. 8.
    Doll D, Gertler R, Maak M et al (2009) Reduced lymph node yield in rectal carcinoma specimen after neoadjuvant radiochemotherapy has no prognostic relevance. World J Surg 33:340–347PubMedCrossRefGoogle Scholar
  9. 9.
    Gospodarowicz MK, Miller D, Groome PA et al (2004) The process of continuous improvement of the TNM classification. Cancer 100:1–5PubMedCrossRefGoogle Scholar
  10. 10.
    Gunderson LL, Jessup MJ, Sargent DJ et al (2010) Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end-results and rectal pooled analysis outcomes. J Clin Oncol 28:256–263PubMedCrossRefGoogle Scholar
  11. 11.
    Horvath SM, Morgan JM, Williams GT (2006) The new (6th edition) TNM classification of colorectal cancer: a stage too far. Gut 53:A21Google Scholar
  12. 12.
    Kikuchi R, Takano M, Takagi K, et al (1995) Management of early invasive colorectal cancer: risk of recurrence and clinical guidelines. Dis Colon Rectum 38:1286–1295Google Scholar
  13. 13.
    Kim JW (2011) The clinical usefulness of the sentinel lymph node in rectal cancer: do we believe in it ? J Korean Soc Coloproctol 27:51–52PubMedCrossRefGoogle Scholar
  14. 14.
    Klos CL, Shellito PC, Rattner DW et al (2010) The effect of neoadjuvant chemoradiation therapy on the prognostic value of lymph nodes after rectal cancer surgery. Am J Surg 200:440–445PubMedCrossRefGoogle Scholar
  15. 15.
    Kobayashi H, Mochizuki H, Kato T,et al (2011) Lymph node ratio is a powerful prognostic index in patients with stage III distal rectal cancer: a Japanese multicenter study. Int J Colorectal Dis 26:891-896PubMedCrossRefGoogle Scholar
  16. 16.
    Lange MM, Buunen M, van de Velde CJ et al (2008) Level of arterial ligation in rectal cancer surgery: low tie preferred over high tie. A review. Dis Colon Rectum 51:1139–1145PubMedCrossRefGoogle Scholar
  17. 17.
    Ludman L, Shepherd NA (2005) Serosal involvement in gastro-intestinal cancer: its assessment and significance. Histopathology 47:123–131CrossRefGoogle Scholar
  18. 18.
    Mekenkamp LJM, van Krieken JHJM, Marijnen CAM et al (2009) Lymph node retrieval in rectal cancer is dependent on many factors – the role of the tumour, the patient, the surgeon, the radiotherapist, and the pathologist. Am J Surg Pathol 33:1547–1553PubMedCrossRefGoogle Scholar
  19. 19.
    Messerini L, Cianchi F, Cortesini C et al (2006) Incidence and prognostic significance of occult tumor cells in lymph nodes from patients with stage IIA colorectal carcinoma. Hum Pathol 37:1259–1267PubMedCrossRefGoogle Scholar
  20. 20.
    Nagtegaal ID, Quirke P (2007) Colorectal tumour deposits in the mesorectum and pericolon: a critical review. Histopathology 51:141–149PubMedCrossRefGoogle Scholar
  21. 21.
    Nagtegaal ID, Quirke P (2010) Revised staging: is it really better, or do we not know? J Clin Oncol 28(23):e397–e398, author reply e399–400PubMedCrossRefGoogle Scholar
  22. 22.
    Nagtegaal ID, Tot T, Jayne DG et al (2011) Lymph nodes, tumor deposits, and TNM: are we getting better? J Clin Oncol 29:2487–2492PubMedCrossRefGoogle Scholar
  23. 23.
    Penninckx F (2009) About sentinels and airstrikes. Colorectal Dis 11:441–442PubMedCrossRefGoogle Scholar
  24. 24.
    Peschaud F, Benoist S, Julié C, et al (2008) The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer. Ann Surg 248:1067-1073PubMedCrossRefGoogle Scholar
  25. 25.
    Pirro N, Sielezneff I, Ouaissi M et al (2009) Que savons-nous du drainage lymphatique due rectum ? (What do we know about lymphatic drainage of the rectum?). Gastroenterol Clin Biol 33:138–146PubMedCrossRefGoogle Scholar
  26. 26.
    Pollheimer MJ, Kornprat P, Pollheimer VS et al (2010) Clinical significance of pT- sub-classification in surgical pathology of colorectal cancer. Int J Colorectal Dis 25:187–196PubMedCrossRefGoogle Scholar
  27. 27.
    Quirke P, Williams GT, Ectors N et al (2007) The future of the TNM staging system in colorectal cancer: time for a debate? Lancet Oncol 8:651–657PubMedCrossRefGoogle Scholar
  28. 28.
    Quirke P, Cuvelier C, Ensari A et al (2010) Evidence-based medicine: the time has come to set standards for staging. J Pathol 221:357–360PubMedGoogle Scholar
  29. 29.
    Quirke P, Risio M, Lambert R et al (2011) Quality assurance in pathology in colorectal cancer screening and diagnosis – European recommendations. Virchows Arch 458:1–19PubMedCrossRefGoogle Scholar
  30. 30.
    Rosenberg R, Friederichs J, Schuster T,et al (2008) Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period. Ann Surg 248:968-978PubMedCrossRefGoogle Scholar
  31. 31.
    Sarma DP (1988) Dukes’ classification of rectal cancer. South Med J 81:407–408PubMedCrossRefGoogle Scholar
  32. 32.
    Schubert W (1990) Dukes’ classification: American chaos versus British order. Can J Surg 33:8–11PubMedGoogle Scholar
  33. 33.
    Shia J, McManus M, Guillem JG et al (2011) Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapy. Am J Surg Pathol 35:127–134PubMedCrossRefGoogle Scholar
  34. 34.
    Simunovic M, Smith AJ, Heald RJ (2009) Rectal cancer surgery and regional lymph nodes. J Surg Oncol 99:256–259PubMedCrossRefGoogle Scholar
  35. 35.
    Smith KJE, Jones PF, Burke DA et al (2011) Lymphatic vessel distribution in the mucosa and submucosa and potential implications for T1 colorectal tumors. Dis Colon Rectum 54:35–40PubMedCrossRefGoogle Scholar
  36. 36.
    Sobin LH, Wittekind CH, International Union Against Cancer (UICC) (1997) TNM classification on malignant tumours, 5th edn. Wiley-Liss Publications, New YorkGoogle Scholar
  37. 37.
    Sobin LH, Greene FL (2001) TNM classification: clarification of number of regional lymph node for N0. Cancer 92:452PubMedCrossRefGoogle Scholar
  38. 38.
    Sobin LH, Wittekind CH, International Union Against Cancer (UICC) (2002) TNM classification on malignant tumours, 6th edn. Wiley-Liss Publications, New YorkGoogle Scholar
  39. 39.
    Sobin LH, Greene FL (2004) Global TNM advisory group. Cancer 100:1106PubMedCrossRefGoogle Scholar
  40. 40.
    Sobin LH, Gospodarowicz MK, Wittekind C (2009) TNM classification of malignant tumours, 7th edn. Wiley-Blackwell, New YorkGoogle Scholar
  41. 41.
    Sobin LH, Compton CA, Gospodarowicz M et al (2010) “Evidence-based medicine: the time has come to set standards for staging”. Is a radical overhaul really needed? J Pathol 221:361–362, Invited ResponsePubMedGoogle Scholar
  42. 42.
    Valentini V, Aristei C, Glimelius B et al (2009) Multidisciplinary rectal cancer management: 2nd European rectal cancer consensus conference (EURECA-CC2). Radiother Oncol 92:148–163PubMedCrossRefGoogle Scholar
  43. 43.
    Van der Pas MHGM, Meijer S, Hoekstra OS et al (2011) Sentinel-lymph-node procedure in colon and rectal cancer: a systemic review and meta-analysis. Lancet Oncol 12:540–550PubMedCrossRefGoogle Scholar
  44. 44.
    Washington MK, Berlin J, Branton P et al (2010) Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum. Arch Pathol Lab Med 133:1539–1551Google Scholar
  45. 45.
    Wittekind Ch, Green FL, Henson DE et al (eds) (2003) TNM supplement: a commentary on uniform use, 3rd edn. Wiley-Liss Inc, New YorkGoogle Scholar
  46. 46.
    Yano H, Moran BJ (2008) The incidence of lateral pelvic side-wall nodal involvement in low rectal cancer may be similar in Japan and the west. Br J Surg 95:33–49PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  1. 1.Department of Imaging and PathologyUniversity LeuvenLeuvenBelgium
  2. 2.Activity Center BiobankingUniversity Hospitals LeuvenLeuvenBelgium

Personalised recommendations